HNRNPA2B1 and hepatocellular carcinoma: Additionally, miR503HG serves as a tumor suppressor in HCC progression by decreasing hnRNPA2B1 expression via a ubiquitin-proteasome pathway, thus eventually suppressing NF-κB signaling pathway (Wang et al., 2018).